Discover the full insider trade history of 경보제약, a publicly traded company based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 경보제약 has recorded 1 public disclosures. Market capitalisation: €143.7bn. The latest transaction was filed on 5 March 2026 (Purchase). Among the most active insiders: 정희록. The full history is free.